EMA Committee for Medicinal Products for Human Use (CHMP) Recommends the Use of Moderna's BA.1 Targeting Bivalent COVID-19 Booster in Children (6-11 Years) In the European UnionAccesswire • 12/16/22
Moderna's CEO predicts how the biotech's work in cancer vaccines could transform healthcare, starting with your annual physicalBusiness Insider • 12/14/22
Moderna rockets higher as vaccine offers glimpse of 'new paradigm ' in cancer treatmentProactive Investors • 12/14/22
Moderna Soars On Cancer Vaccine News: Here's What To Watch Going Forward - Moderna (NASDAQ:MRNA)Benzinga • 12/13/22
Moderna just used a personalized vaccine to treat cancer, and it could signal a major breakthrough in how we treat the diseaseBusiness Insider • 12/13/22
Moderna soars 24% after the drug maker posts upbeat results from cancer vaccine trialBusiness Insider • 12/13/22
Is Moderna Stock A Buy On A Bullish Update For Its Cancer Vaccine?Investors Business Daily • 12/13/22